Investornewsbreaks Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Appoints Gary Ainsworth As Vice President, Market Access
Tonix Pharmaceuticals (NASDAQ: TNXP) has appointed Gary Ainsworth as Vice President, market Access, as the company prepares for the potential FDA approval of TNX-102 SL, a non-opioid analgesic for ...
Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Gary Ainsworth as Vice President of Market Access
Mr. Ainsworth brings over two decades of industry and market access experience to Tonix U.S. Food and Drug Administration ...
Investornewsbreaks Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) To Present At Neuroscience And Biotech Investor Conferences
Tonix Pharmaceuticals (NASDAQ: TNXP) , a biopharmaceutical company focused on marketed products and development candidates, announced its participat ...
Tonix Pharmaceuticals to Present at Two Upcoming January Investor Conferences
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products ...
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 8.4% – Should You Sell?
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) fell 8.4% on Wednesday . The stock traded as low as $0.32 and last traded at $0.33. 80,811,016 shares traded hands during trading, ...